ICPT logo

ICPT Cash From Financing

Annual CFF

-$267.32 M
-$268.43 M-24010.20%

December 31, 2022

Summary

Performance

1-Year Change

-24010.2%

3-Year Change

-158.43%

5-Year Change

-9519.17%

15-Year Change

-9519.17%

ICPT Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$565.47 M
ICPT annual cash flow from financing activities is currently -147.27% below its historical high of $565.47 million

3-Year Low

-$267.32 M
ICPT annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ICPT previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
ICPT next annual earnings announcement has not yet been scheduled

OtherICPTcash flowmetrics:

Annual CFI

$261.85 M
ICPT annual cash flow from investing activities is $261.85 million

Annual CFO

-$26.78 M
ICPT annual cash flow from operations is -$26.78 million

Annual FCF

-$27.35 M
ICPT annual free cash flow is -$27.35 million

Annual CAPEX

$568.00 K
ICPT annual capital expenditures is $568.00 thousand

Quarterly CFF

-$110.00 M
-$109.96 M-255711.63%

September 30, 2023

Summary

Performance

3-Month Change

-255711.63%

1-Year Change

+57.27%

3-Year Change

-48572.12%

5-Year Change

-8816.24%

ICPT Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$450.60 M
ICPT quarterly cash flow from financing activities is currently -124.41% below its historical high of $450.60 million

3-Year Low

-$257.40 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
ICPT previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
ICPT next earnings announcement has not yet been scheduled

OtherICPTcash flowmetrics:

Quarterly CFI

$59.77 M
ICPT quarterly cash flow from investing activities is $59.77 million

Quarterly CFO

$16.69 M
ICPT quarterly cash flow from operations is $16.69 million

Quarterly FCF

$16.67 M
ICPT quarterly free cash flow is $16.67 million

Quarterly CAPEX

$13.00 K
ICPT quarterly capital expenditures is $13.00 thousand

TTM CFF

-$115.97 M
+$147.40 M+55.97%

September 30, 2023

Summary

Performance

3-Month Change

+55.97%

1-Year Change

+55.84%

3-Year Change

-2270.47%

5-Year Change

-125.35%

ICPT TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$566.44 M
ICPT TTM cash flow from financing activities is currently -120.47% below its historical high of $566.44 million

3-Year Low

-$267.32 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
ICPT previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
ICPT next earnings announcement has not yet been scheduled

OtherICPTcash flowmetrics:

TTM CFI

$161.11 M
ICPT TTM cash flow from investing activities is $161.11 million

TTM CFO

-$63.02 M
ICPT TTM cash flow from operations is -$63.02 million

TTM FCF

-$62.83 M
ICPT TTM free cash flow is -$62.83 million

TTM CAPEX

-$186.00 K
ICPT TTM capital expenditures is -$186.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ICPT Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10000.0%+57.3%+55.8%
3 y3 years-158.4%-10000.0%-2270.5%
5 y5 years-9519.2%-8816.2%-125.3%

ICPT Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%at low>+9999.0%+134.0%-6258.7%+130.5%
5 y5-year-158.4%at low-1970.7%+134.0%-125.3%+130.5%
alltimeall time-147.3%at low-124.4%+134.0%-120.5%+130.5%

Intercept Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2023
-
-$110.00 M(>+9900.0%)
-$115.97 M(-56.0%)
Jun 2023
-
-$43.00 K(-83.1%)
-$263.37 M(-1.5%)
Mar 2023
-
-$254.00 K(-95.5%)
-$267.25 M(-0.0%)
Dec 2022
-$267.32 M(<-9900.0%)
-$5.67 M(-97.8%)
-$267.32 M(+1.8%)
Sep 2022
-
-$257.40 M(+6459.7%)
-$262.61 M(>+9900.0%)
Jun 2022
-
-$3.92 M(+1134.0%)
-$1.82 M(-196.5%)
Mar 2022
-
-$318.00 K(-67.0%)
$1.88 M(+68.4%)
Dec 2021
$1.12 M(-261.3%)
-$965.00 K(-128.5%)
$1.12 M(-42.0%)
Sep 2021
-
$3.39 M(-1613.4%)
$1.93 M(-214.1%)
Jun 2021
-
-$224.00 K(-79.3%)
-$1.69 M(+65.1%)
Mar 2021
-
-$1.08 M(+594.2%)
-$1.02 M(+47.6%)
Dec 2020
-$693.00 K(-100.2%)
-$156.00 K(-31.0%)
-$693.00 K(-113.0%)
Sep 2020
-
-$226.00 K(-151.1%)
$5.34 M(-17.3%)
Jun 2020
-
$442.00 K(-158.7%)
$6.46 M(-98.6%)
Mar 2020
-
-$753.00 K(-112.8%)
$456.61 M(-0.2%)
Dec 2019
$457.52 M(+73.6%)
$5.88 M(+559.2%)
$457.52 M(+1.2%)
Sep 2019
-
$892.00 K(-99.8%)
$452.08 M(-0.1%)
Jun 2019
-
$450.60 M(>+9900.0%)
$452.45 M(+71.9%)
Mar 2019
-
$152.00 K(-65.5%)
$263.22 M(-0.1%)
Dec 2018
$263.55 M(+9186.3%)
$440.00 K(-65.1%)
$263.55 M(-0.1%)
Sep 2018
-
$1.26 M(-99.5%)
$263.87 M(+0.3%)
Jun 2018
-
$261.36 M(>+9900.0%)
$263.03 M(+9419.9%)
Mar 2018
-
$481.00 K(-36.8%)
$2.76 M(-2.6%)
Dec 2017
$2.84 M
$761.00 K(+77.0%)
$2.84 M(+5.9%)
DateAnnualQuarterlyTTM
Sep 2017
-
$430.00 K(-60.6%)
$2.68 M(-99.4%)
Jun 2017
-
$1.09 M(+96.2%)
$413.12 M(-0.1%)
Mar 2017
-
$556.00 K(-7.6%)
$413.45 M(-0.2%)
Dec 2016
$414.38 M(-26.7%)
$602.00 K(-99.9%)
$414.38 M(-0.1%)
Sep 2016
-
$410.87 M(>+9900.0%)
$414.90 M(+8351.8%)
Jun 2016
-
$1.42 M(-4.4%)
$4.91 M(-98.7%)
Mar 2016
-
$1.49 M(+32.9%)
$372.33 M(-34.2%)
Dec 2015
$565.47 M(+196.1%)
$1.12 M(+26.3%)
$565.47 M(+0.0%)
Sep 2015
-
$885.00 K(-99.8%)
$565.42 M(-0.2%)
Jun 2015
-
$368.84 M(+89.5%)
$566.44 M(+47.8%)
Mar 2015
-
$194.62 M(>+9900.0%)
$383.15 M(+100.6%)
Dec 2014
$190.98 M(+189.1%)
$1.07 M(-43.7%)
$190.98 M(+0.2%)
Sep 2014
-
$1.90 M(-99.0%)
$190.51 M(+0.0%)
Jun 2014
-
$185.55 M(+7444.0%)
$190.49 M(+178.3%)
Mar 2014
-
$2.46 M(+313.9%)
$68.44 M(+3.6%)
Dec 2013
$66.07 M(-39.1%)
$594.30 K(-68.4%)
$66.07 M(-54.2%)
Sep 2013
-
$1.88 M(-97.0%)
$144.26 M(-16.2%)
Jun 2013
-
$63.51 M(>+9900.0%)
$172.10 M(+58.5%)
Mar 2013
-
$87.40 K(-99.9%)
$108.56 M(+0.1%)
Dec 2012
$108.42 M(<-9900.0%)
$78.79 M(+165.1%)
$108.42 M(+265.9%)
Sep 2012
-
$29.71 M(<-9900.0%)
$29.63 M(<-9900.0%)
Jun 2012
-
-$23.20 K(-60.3%)
-$81.70 K(+39.7%)
Mar 2012
-
-$58.50 K
-$58.50 K
Dec 2011
-$249.70 K(-101.0%)
-
-
Dec 2010
$24.62 M
-
-

FAQ

  • What is Intercept Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals annual CFF year-on-year change?
  • What is Intercept Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals quarterly CFF year-on-year change?
  • What is Intercept Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals TTM CFF year-on-year change?

What is Intercept Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of ICPT is -$267.32 M

What is the all time high annual CFF for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high annual cash flow from financing activities is $565.47 M

What is Intercept Pharmaceuticals annual CFF year-on-year change?

Over the past year, ICPT annual cash flow from financing activities has changed by -$268.43 M (-24010.20%)

What is Intercept Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of ICPT is -$110.00 M

What is the all time high quarterly CFF for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high quarterly cash flow from financing activities is $450.60 M

What is Intercept Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, ICPT quarterly cash flow from financing activities has changed by +$147.40 M (+57.27%)

What is Intercept Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of ICPT is -$115.97 M

What is the all time high TTM CFF for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high TTM cash flow from financing activities is $566.44 M

What is Intercept Pharmaceuticals TTM CFF year-on-year change?

Over the past year, ICPT TTM cash flow from financing activities has changed by +$146.64 M (+55.84%)